Metraipolis › archive › dc_ef7425457a2b

The incidence of anti-HMGCR immune-mediated necrotizing myopathy: an Australian and UK retrospective multi-site cohort study — Europe PMC PMID:40347460

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40347460
DOI
10.1093/rheumatology/keaf238
License (as archived)
solo-consultazione
Archived
2026-11-10T04:39:12.636Z
SHA-256 of the archived text
0846c48390fc35f69c36bde6a215981cb94c5f0222eafb0c89b4458d67651cdf
Stable URL of this page
https://metraipolis.com/documento/dc_ef7425457a2b

How to cite

The incidence of anti-HMGCR immune-mediated necrotizing myopathy: an Australian and UK retrospective multi-site cohort study — Europe PMC PMID:40347460 — Europe PMC (en), https://europepmc.org/article/MED/40347460 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef7425457a2b (Metraipolis archive dc_ef7425457a2b, sha256 0846c48390fc35f69c36bde6a215981cb94c5f0222eafb0c89b4458d67651cdf)
BibTeX
@misc{dcef7425457a2b,
  title = {The incidence of anti-HMGCR immune-mediated necrotizing myopathy: an Australian and UK retrospective multi-site cohort study — Europe PMC PMID:40347460},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40347460},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef7425457a2b; sha256 0846c48390fc35f69c36bde6a215981cb94c5f0222eafb0c89b4458d67651cdf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40347460. Agents can read the archived copy with the MCP tool read_document.